Spectral Medical Inc.
TSX:EDT.TOMedical - Diagnostics & Research
-$0.02 today
- Market cap
- $306.00M
- Beta
- 0.23
- P/E (TTM)
- -10.5
- EPS (TTM)
- -$0.13
Volume 0.02M
Average 0.06M
EDT.TO Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
Spectral Medical Inc.TSX: EDT.TO
Gross Margin · Q1 FY2026 · quarter ended Mar 2026
Gross margin narrows to -229.1%
Gross margin was -229.1% in Q1 FY2026, down 307.2 pp from a year earlier. On a trailing-twelve-month basis it was -79.2%, down 128.4 pp year over year. Over 3 fiscal years it narrowed by 270.1 pp.
Context
- Gross margin widened in 1 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -211.1%
- Year-over-year change
- -255.7pp
| Period | Period end | Gross Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -211.1% | -255.7pp |
| FY2024 | 2024-12-31 | 44.5% | +3.1pp |
| FY2023 | 2023-12-31 | 41.4% | -17.5pp |
| FY2022 | 2022-12-31 | 59.0% | +0.7pp |
| FY2021 | 2021-12-31 | 58.3% | — |
Gross Margin vs competitors
How EDT.TO compares with its peers on the latest reported figures
- EDT.TO's LTM Mar 2026 gross margin of -79.2% is the lowest of the 7 companies compared; the peer median is 65.6%.
- Its year-over-year change of -128.4 pp is the lowest of 7, against a peer median of -2.0 pp.
- Over three fiscal years its change of -270.1 pp compares with a peer median of +11.4 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 92.2% | +1.9 pp | -2.8 pp | |
| LTM Mar 2026 | 74.5% | +2.6 pp | -14.9 pp | |
PRN.TOProfound Medical Corp. | LTM Mar 2026 | 71.0% | +4.1 pp | +25.6 pp |
| LTM Mar 2026 | 60.1% | -15.0 pp | -6.9 pp | |
| LTM Mar 2026 | 31.5% | -23.2 pp | +32.8 pp | |
| LTM Mar 2026 | 23.6% | -5.9 pp | +54.0 pp | |
| LTM Mar 2026 | -79.2% | -128.4 pp | -270.1 pp | |
| FY2025 | — | — | — | |
| Peer median (excluding EDT.TO) | 65.6% | -2.0 pp | +11.4 pp | |
Competitors are the stored peer set for EDT.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2M | 1.67M | 1.6M | 2.29M | 2.44M |
| Cost of Revenue | 832K | 684K | 936K | 1.27M | 7.6M |
| Gross Profit | 1.16M | 983K | 662K | 1.02M | (5.16M) |
| Gross Margin | 58.3% | 59.0% | 41.4% | 44.5% | -211.1% |
| Research & Development | 0 | 0 | 4.68M | 3.97M | 4.33M |
| Selling, General & Admin | 7.01M | 8.64M | 11.29M | 11.62M | 11.73M |
| Operating Expenses | 7.86M | 9.43M | 12.08M | 13.02M | 6.53M |
| Depreciation & Amortization | 294K | 272K | 218K | 251K | 250K |
| EBITDA | (6.38M) | (7.18M) | (13.96M) | (11.97M) | (11.44M) |
| EBITDA Margin | -319.4% | -430.7% | -873.3% | -523.5% | -468.3% |
| Operating Income | (6.66M) | (8.45M) | (11.42M) | (12M) | (11.69M) |
| Operating Margin | -333.5% | -506.7% | -714.7% | -524.8% | -478.5% |
| Interest Income | 0 | 0 | 0 | 0 | 5.39M |
| Interest Expense | 28K | 176K | 1.33M | 3.18M | 5.16M |
| Other Income / Expenses | (40K) | 819K | (4.09M) | (3.4M) | (36M) |
| Income Before Tax | (6.96M) | (7.63M) | (15.51M) | (15.4M) | (47.69M) |
| Pre-Tax Margin | -348.6% | -457.6% | -970.4% | -673.4% | -1952.9% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (8.79M) | (11.28M) | (15.66M) | (15.4M) | (47.69M) |
| Net Margin | -440.1% | -676.7% | -980.1% | -673.8% | -1953.0% |
| EPS (Basic) | (0.03) | (0.04) | (0.06) | (0.05) | (0.17) |
| EPS (Diluted) | (0.03) | (0.04) | (0.06) | (0.05) | (0.17) |
| Weighted Avg Shares | 252.46M | 269.84M | 278.56M | 281.08M | 287.21M |
| Weighted Avg Shares (Diluted) | 252.46M | 269.84M | 278.56M | 281.08M | 287.21M |
Spectral Medical Inc.
TSX:EDT.TO
Intrinsic Alpha fair value
Locked
Current Price
$1.04
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.